| Code | 99839 | ||||||||||
| MA number | 44/0199/06-S | ||||||||||
| Product Form: | con inf 4x20 ml/60 mg (liek.inj.skl.) | ||||||||||
| MA Status: | D - Marketing Authorisation valid for an unlimited period | ||||||||||
| Type of procedure: | Mutual recognition procedure | ||||||||||
| MAH, country: | medac Gesellschaft für klinische Spezialpräparate m.b.H., Germany | ||||||||||
| Therapeutic Class: | 44 - CYTOSTATICA | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 48 | ||||||||||
| Container: | glass vial | ||||||||||
| Route of admin.: | Intravenous use |
| Prescription Status: | Medicinal product subject to medical prescription. |
| Legal basis: | Article 10a well-established use application |
| MA issued: | 11.05.2006 |
| Pediatric warnings: | Yes |
| SPC: |
SPC_Pamifos_06.2023.pdf
|
| PIL: |
PIL_Pamifos_06.2023.pdf
|
| Dokument: |
Pamifos_Karta pacienta.pdf
|
| Safety feature | Yes |
| Data update: | 29.05.2019 |
